The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4200-4203

  Yu, De Chao ^a   Chen, Yu ^a   Seng, Monica ^a   Dilley, Jeanette ^a   Henderson, Daniel R ^a  

^a Calydon Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBASIN; PROSTATE SPECIFIC ANTIGEN;

ADENOVIRUS 5; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALYDON VIRUS 787; CANCER CELL DESTRUCTION; CANCER SIZE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR XENOGRAFT; VIRUS GENE; VIRUS REPLICATION;

EID: 0033199188     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1998. CA Cancer J. Clin., 48: 6-29, 1998.
2. Small, E. J. Prostate cancer, incidence, management and outcomes. Drugs Aging, 13: 71-81, 1998.
3. Bare, R. L., and Torti, F. M. Endocrine therapy of prostate cancer. Cancer Treat Res., 94: 69-87, 1998.
4. Tyrrell, C. J., Kaisary, A. V., Iversen, P., Anderson, J. B., Baert, L., Tammela, T., Chamberlain, M., Webster, A., and Blackledge, G. A randomised comparison of "Casodex" (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur. Urol., 33: 447-456, 1998.
5. Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., and Henderson, D. R. Prostate-specific antigen expression in regulated by an upstream enhancer. J. Biol. Chem., 271: 7043-7051, 1996.
6. Rodriguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., and Henderson, D. R. Prostate-attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen positive prostate cancer cells. Cancer Res., 57: 2559-2563, 1997.
7. Yu, D-C., Sakamoto, G. T., and Henderson, D. R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res., 59: 1498-1504, 1999.
8. Bett, A. J., Haddara, W., Prevec, L., and Graham, F. L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA, 91: 8802-8806, 1994.
9. Haj-Ahmad, Y., and Graham, F. L. Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J. Virol., 57: 267-274, 1986.
10. Ghosh-Choudhury, G., Haj-Ahmad, Y., Brinkley, P., Rudy, J., and Graham, F. L. Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene, 50: 161-171, 1986.
11. Graham, F. L. Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol., 8: 85-87, 1990.
12. Robbins, P. D., Tahara, H., and Ghivizzani, S. C. Viral vectors for gene therapy. Trends Biotechnol., 16: 35-40, 1998.
13. Wivel, N. A., and Wilson, J. M. Methods of gene delivery. Hematol. Oncol. Clin. North Am., 12: 483-501, 1998.
14. Ilan, Y., Droguett, G., Chowdhury, N. R., Li, Y., Sengupta, K., Thummala, N. R., Davidson, A., Chowdhury, J. R., and Horwitz, M. S. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA, 94: 2587-2592, 1997.
15. Ginsberg, H. S., Lundholm-Beauchamp, U., Horswood, R. L., Pernis, B., Wold, W. S., Chanock, R. M., and Prince, G. A. Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc. Natl. Acad. Sci. USA, 86: 3823-3827, 1989.
16. Wold, W. S., Tollefson, A. E., and Hermiston, T. W. E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol., 199: 237-274, 1995.
17. Tollefson, A. E., Ryerse, J. S., Scaria, A., Hermiston, T. W., and Wold, W. S. The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. Virology, 220: 152-162, 1996.
18. Tollefson, A. E., Scaria, A., Hermiston, T. W., Ryerse, J. S., Wold, L. J., and Wold, W. S. The adenovirus death protein (E3-11.6K) is required al very late stages of infection for efficient cell lysis and release of adenovirus from infected cells. J. Virol., 70: 2296-2306, 1996.
19. Hausmann, J., Ortmann, D., Witt, E., Veit, M., and Seidel, W. Adenovirus death protein, a transmembrane protein encoded in the E3 region, is palmitoylated at the cytoplasmic tail. Virology, 244: 343-351, 1998.
20. Korner, H., and Burgert, H. G. Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T-lymphoma cell line. J. Virol., 68: 1442-1448, 1994.
21. Flomenberg, P., Gutierrez, E., and Hogan, K. T. Identification of class IMHC regions which bind to the adenovirus E3-19k protein. Mol. Immunol., 31: 1277-1284, 1994.
22. Li, Y., Kang, J., and Horwitz, M. S. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor a-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol., 18: 1601-1610, 1998.
23. Elsing, A., and Burgert, H. G. The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization. Proc. Natl. Acad. Sci. USA, 95: 10072-10077, 1998.
24. Dimitrov, T., Krajcsi, P., Hermiston, T. W., Tollefson, A. E., Hannink, M., and Wold, W. S. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J. Virol., 71: 2830-2837, 1997.
25. Vinogradova, O., Carlin, C., Sonnichsen, F. D., and Sanders, C. R., II. A membrane setting for the sorting motifs present in the adenovirus E3-13.7 protein which down-regulates the epidermal growth factor receptor. J. Biol. Chem., 275: 17343-17350, 1998.
26. Greenberg, N. M., DeMayo, F. J., Sheppard, P. C., Barrios, R., Lebovitz, R., Finegold, M., Angelopoulou, R., Dodd, J. G., Duckworth, M. L., Rosen, J. M., and Matusik, R. J. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol., 8: 230-239, 1994.
27. Yan, Y., Sheppard, P. C., Kasper, S., Lin, L., Hoare, S., Kapoor, A., Dodd, J. G., Duckworth, M. L., and Matusik, R. J. Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice. Prostate, 32: 129-139, 1997.
28. Brookes, D. E., Zandvliet, D., Watt, F., Russell, P. J., and Molloy, P. L. Relative activity and specificity of promoters from prostate-expressed genes. Prostate, 35: 18-26, 1998.
29. McKinnon, R. D., Bacchetti, S., and Graham, F. L. Tn5 mutagenesis of the transforming genes of human adenovirus type 5. Gene, 19: 33-42, 1982.
30. Graham, F. L., Smiley, J., Russell, W. C., and Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol., 36: 59-74, 1977.